6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Selected Clinical ... inhibitors in CVD ... SGLT2 #inhibitors #EBM ... visualabstract #table ... #CVD #CKD
Characteristics of Common Lipid Disorders
Polygenic hypercholesterolemia
Atherogenic dyslipidemia
 • Frequently accompanied by central obesity or diabetes
Familial hypercholesterolemia,
history of premature CHD ... individuals exhibit CHD ... Family history of CHD ... Family history, CHD ... #comparison #table
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... factors: Age>60, CKD ... , CHF, high rate ... Reactions #hematology #diagnosis ... #comparison #table
Approach to Eosinophilic Lung Diseases
 • Acute Eosinophilic Pneumonia (< 1 wk) - ~30yo, M; Recent
to Eosinophilic Lung ... Diseases • Acute ... Hx of asthma, CF ... #differential #diagnosis ... #comparison #table
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Ischemic heart disease ... b) CHF c) ... Change in clinical ... unless prior heart/lung ... stratification #diagnosis
Fungal Biomarkers: Beta-D-Glucan and Aspergillus Galactomannan
Beta-D-Glucan:
 • Polysaccharide cell wall component of many fungi
 • Pathogens:
cut-offs defined in clinical ... colonization vs invasive disease ... SOT recipients, CGD ... Galactomannan #diagnosis ... #comparison